An Uncommon Side Effect of Rivaroxaban: A Drug-Induced Liver Injury

Rivaroxaban is rarely associated with drug-induced liver injury (DILI). A 57-year-old male was sent to the emergency room from an endocrine clinic for a presyncope evaluation. His exam was non-focal, and his laboratory work was remarkable for the hepatocellular pattern of liver injury. Upon detailed...

Full description

Saved in:
Bibliographic Details
Published inCureus Vol. 15; no. 9; p. e45949
Main Authors Karki, Bhesh R, Jasaraj, Ranjit B, Jha, Suman K, Maisuradze, Nodari, Yu, Qi
Format Report
LanguageEnglish
Published 01.09.2023
Online AccessGet full text

Cover

More Information
Summary:Rivaroxaban is rarely associated with drug-induced liver injury (DILI). A 57-year-old male was sent to the emergency room from an endocrine clinic for a presyncope evaluation. His exam was non-focal, and his laboratory work was remarkable for the hepatocellular pattern of liver injury. Upon detailed assessment, he was found to have DILI due to rivaroxaban. The liver function tests improved after its discontinuation. This case emphasizes the need for early recognition and timely intervention to prevent further hepatotoxicity from the culprit drug.
Bibliography:ObjectType-Case Study-2
content type line 59
SourceType-Reports-1
ObjectType-Report-1
ISSN:2168-8184
2168-8184
DOI:10.7759/cureus.45949